Silicon Laboratories Stock Performance
| SLAB Stock | USD 133.55 7.24 5.73% |
The entity has a beta of 1.99, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Silicon Laboratories will likely underperform. At this point, Silicon Laboratories has a negative expected return of -0.0982%. Please make sure to validate Silicon Laboratories' kurtosis, and the relationship between the maximum drawdown and rate of daily change , to decide if Silicon Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Silicon Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Silicon Laboratories is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 7.91 | Five Day Return 13.79 | Year To Date Return 1.01 | Ten Year Return 146.03 | All Time Return 82.07 |
1 | Acquisition by Sandeep Kumar of 8836 shares of Silicon Laboratories subject to Rule 16b-3 | 02/14/2025 |
2 | Disposition of 1000 shares by Bock William G of Silicon Laboratories at 149.43 subject to Rule 16b-3 | 02/18/2025 |
3 | Disposition of 1113 shares by Hollister John C of Silicon Laboratories at 156.91 subject to Rule 16b-3 | 03/04/2025 |
4 | American Century Companies Inc. Raises Holdings in Silicon Laboratories Inc. | 03/28/2025 |
5 | Analog Devices Stock Jumps 4.1 percent Will It Continue to Soar | 04/08/2025 |
6 | Stifel Adjusts Price Target for Silicon Labs Amid Tariff Concerns SLAB Stock News | 04/17/2025 |
7 | Silicon Labs Announces First Quarter 2025 Earnings Webcast | 04/22/2025 |
8 | Acquisition by Luther Sherri R of 1843 shares of Silicon Laboratories subject to Rule 16b-3 | 04/24/2025 |
9 | Acquisition by Bock William G of 1843 shares of Silicon Laboratories subject to Rule 16b-3 | 04/25/2025 |
10 | Disposition of 546 shares by Wyatt Christy of Silicon Laboratories at 104.45 subject to Rule 16b-3 | 05/06/2025 |
11 | Skyworks Reports Q2 Fiscal 2025 Results | 05/07/2025 |
12 | ACM Research, Inc. Tops Q1 Earnings and Revenue Estimates | 05/08/2025 |
13 | Silicon Laboratories Q1 2025 Earnings Preview | 05/12/2025 |
| Begin Period Cash Flow | 227.5 M |
Silicon Laboratories Relative Risk vs. Return Landscape
If you would invest 15,072 in Silicon Laboratories on February 12, 2025 and sell it today you would lose (1,717) from holding Silicon Laboratories or give up 11.39% of portfolio value over 90 days. Silicon Laboratories is currently does not generate positive expected returns and assumes 4.3365% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Silicon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Silicon Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silicon Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Silicon Laboratories, and traders can use it to determine the average amount a Silicon Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0227
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SLAB |
Estimated Market Risk
| 4.34 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Silicon Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Silicon Laboratories by adding Silicon Laboratories to a well-diversified portfolio.
Silicon Laboratories Fundamentals Growth
Silicon Stock prices reflect investors' perceptions of the future prospects and financial health of Silicon Laboratories, and Silicon Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Silicon Stock performance.
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.0776 | ||||
| Profit Margin | (0.33) % | ||||
| Operating Margin | (0.17) % | ||||
| Current Valuation | 3.16 B | ||||
| Shares Outstanding | 32.47 M | ||||
| Price To Earning | 260.36 X | ||||
| Price To Book | 3.27 X | ||||
| Price To Sales | 7.02 X | ||||
| Revenue | 584.39 M | ||||
| Gross Profit | 312.19 M | ||||
| EBITDA | (104.92 M) | ||||
| Net Income | (191.01 M) | ||||
| Cash And Equivalents | 499.92 M | ||||
| Cash Per Share | 41.35 X | ||||
| Total Debt | 15.55 M | ||||
| Debt To Equity | 0.34 % | ||||
| Current Ratio | 7.90 X | ||||
| Book Value Per Share | 33.27 X | ||||
| Cash Flow From Operations | (13.91 M) | ||||
| Earnings Per Share | (5.93) X | ||||
| Market Capitalization | 4.1 B | ||||
| Total Asset | 1.22 B | ||||
| Retained Earnings | 1 B | ||||
| Working Capital | 504.15 M | ||||
| Current Asset | 490.85 M | ||||
| Current Liabilities | 139.69 M | ||||
About Silicon Laboratories Performance
By analyzing Silicon Laboratories' fundamental ratios, stakeholders can gain valuable insights into Silicon Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Silicon Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Silicon Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 96.06 | 65.55 | |
| Return On Tangible Assets | 0.05 | 0.07 | |
| Return On Capital Employed | 0.06 | 0.08 | |
| Return On Assets | 0.04 | 0.05 | |
| Return On Equity | 0.07 | 0.08 |
Things to note about Silicon Laboratories performance evaluation
Checking the ongoing alerts about Silicon Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Silicon Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Silicon Laboratories generated a negative expected return over the last 90 days | |
| Silicon Laboratories has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 584.39 M. Net Loss for the year was (191.01 M) with profit before overhead, payroll, taxes, and interest of 312.19 M. | |
| Silicon Laboratories currently holds about 499.92 M in cash with (13.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 41.35. | |
| Silicon Laboratories has a poor financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Silicon Laboratories Q1 2025 Earnings Preview |
- Analyzing Silicon Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Silicon Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Silicon Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Silicon Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Silicon Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Silicon Laboratories' stock. These opinions can provide insight into Silicon Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Silicon Stock analysis
When running Silicon Laboratories' price analysis, check to measure Silicon Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silicon Laboratories is operating at the current time. Most of Silicon Laboratories' value examination focuses on studying past and present price action to predict the probability of Silicon Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silicon Laboratories' price. Additionally, you may evaluate how the addition of Silicon Laboratories to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |